Hikma Pharmaceuticals (HKMPY)
OTC: HKMPY
· Real-Time Price · USD
48.52
-0.24 (-0.49%)
At close: Oct 15, 2025, 3:59 PM
48.73
0.44%
Pre-market: Oct 15, 2025, 11:12 AM EDT
-0.49% (1D)
| Bid | 48.3 |
| Market Cap | 5.35B |
| Revenue (ttm) | 3.22B |
| Net Income (ttm) | 369.66M |
| EPS (ttm) | 3.34 |
| PE Ratio (ttm) | 14.53 |
| Forward PE | n/a |
| Analyst | n/a |
| Dividends | $2.32 |
| Ask | 48.73 |
| Volume | 636 |
| Avg. Volume (20D) | 2,583.5 |
| Open | 48.73 |
| Previous Close | 48.76 |
| Day's Range | 48.52 - 48.73 |
| 52-Week Range | 43.00 - 59.26 |
| Beta | 0.63 |
| Ex-Dividend Date | Aug 18, 2025 |
About HKMPY
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol HKMPY
Website n/a
2 months ago · seekingalpha.com
Hikma Pharmaceuticals PLC (HKMPF) Q2 2025 Pre Recorded Earnings Call TranscriptHikma Pharmaceuticals PLC (OTCPK:HKMPF) Q2 2025 Pre Recorded Earnings Conference Call August 7, 2025 2:00 AM ET Company Participants Khalid Waleed Hosny Al Nabilsi - Chief Financial Officer Riad Ali M...
2 months ago · seekingalpha.com
Hikma Pharmaceuticals PLC (HKMPF) Q2 2025 Q&A Earnings Call TranscriptHikma Pharmaceuticals PLC (OTCPK:HKMPF) Q2 2025 Q&A Earnings Call August 7, 2025 4:00 AM ET Company Participants Khalid Waleed Hosny Al Nabilsi - Chief Financial Officer Riad Ali Mishlawi - CEO & Dire...
